Tianjin Development FY26 H1 profit attributable to owners falls 5.58% to HK$ 325.22 million; revenue slips 3.53% to HK$ 1.66 billionPUBT·1 hour ago00882-0.97%600535+0.47%
Hong Kong’s Asset Reshuffle: The Financial Tensions of 2026Global Report·2 hours ago009310.00%00288-0.44%
Tianjin Development Unit Lisheng Pharma Posts Sharp Interim Profit DeclineTip Ranks·Aug 20 at 05:37 PM00882-0.97%002393+0.49%
Tianjin Lisheng Pharma, Tianjin Development Holdings subsidiary, posts H1 net profit RMB 80.08 millionPUBT·Aug 20 at 05:20 PM00882-0.97%002393+0.49%
Tianjin Development Holdings sets board meeting to review interim resultsPUBT·Aug 17 at 04:37 AM00882-0.97%
Tianjin Development Holdings files board, committee and management disclosure rosterPUBT·Jul 31 at 04:50 AM00882-0.97%
Tianjin Development Flags Sharp Profit Drop at Lisheng Pharmaceutical for H1 2026Tip Ranks·Jul 14 at 05:37 PM00882-0.97%002393+0.49%
Tianjin Development affiliate Lisheng Pharmaceutical invests RMB 180 million in Industrial Bank wealth productsPUBT·Jun 25 at 05:32 AM601166-3.22%00882-0.97%
Tianjin Development Wins Strong Shareholder Backing at 2026 AGMTip Ranks·Jun 23 at 06:17 AM00882-0.97%
Tianjin Development Holdings AGM backs final dividend of HK 0.0882 a sharePUBT·Jun 23 at 05:35 AM00882-0.97%
Tianjin Development director Wong faces SFC court action over Target Insurance delistingPUBT·Jun 18 at 05:33 AM00882-0.97%
Tianjin Development Secures HK$100 Million Revolving Loan Tied to State Majority ControlTip Ranks·Apr 29 at 07:46 AM00882-0.97%
